Skip to content

Rank of Pharmacists

Ambulatory Care

Board Certified Ambulatory Care Pharmacist — BCACP

Ambulatory care pharmacy practice is the provision of integrated, accessible health care services by pharmacists who are accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community. This is accomplished through direct patient care and medication management for ambulatory patients, long-term relationships, coordination of care, patient advocacy, wellness and health promotion, triage and referral, and patient education and self management. The ambulatory care pharmacists may work in both an institutional and community-based clinic involved in direct care of a diverse patient population. Those who are granted certification in this specialty may use the designation Board Certified Ambulatory Care Pharmacist and the initials BCACP, as long as certification is valid.

Eligibility Requirements

The minimum requirements for this specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction.
  • Completion of four (4) years of practice experience with at least 50% of time spent in ambulatory care pharmacy activities (as defined by the BPS Ambulatory Care Content Outline)
    OR
    Completion of a PGY1 residency * plus one (1) additional year of practice with at least 50% of time spent in ambulatory care pharmacy activities (as defined by the BPS Ambulatory Care Content Outline)
    OR
    Completion of a specialty (PGY2) residency * in ambulatory care pharmacy
    *Effective January 1, 2013, only residencies accredited by the American Society of Health-System Pharmacists are creditable for this purpose.
  • Achieving a passing score on the Ambulatory Care Specialty Certification Examination

Examination Content

(Refer to the Ambulatory Care Pharmacy Content Outlinefor details.)

  • Domain 1: Direct Patient Care (50% of the examination)
  • Domain 2: Practice Management (20% of the examination)
  • Domain 3: Public Health (5% of the examination)
  • Domain 4: Retrieval, generation, interpretation and dissemination of knowledge (15% of the examination)
  • Domain 5: Patient Advocacy (10% of the examination)

Recertification

Pharmacists who earn the designation Board Certified Ambulatory Care Pharmacist (BCACP) will be required to maintain their certification over a seven year period by completing one of the following professional development activities:

  1. Achieving a passing score on the 100-item, multiple-choice objective recertification examination (administered by BPS), based on the content outline for the Ambulatory Care Pharmacy Specialty in their seventh year following initial certification;Or
  2. Earning 100 hours of continuing education credit provided by the professional development programs offered by the American College of Clinical Pharmacy (ACCP) and/or the joint program offered by the American Society of Health-System Pharmacists (ASHP) and the American Pharmacists Association (APhA). No more than 50 hours will be accepted by BPS during the first three years of the certification cycle. Further, Ambulatory Care Pharmacy Preparatory Review and Recertification Courses offered by either of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle.**To achieve the 100 hour requirement, the BCACP may participate in recertification offerings from both BPS-approved ambulatory care pharmacy providers.

Board Certified Ambulatory Care Pharmacists are also required to pay the BPS Annual Certification Maintenance fee of $100 each year for years one through six and a $400 recertification fee in year seven.

Critical Care Pharmacy

Board Certified Critical Care Pharmacist — BCCCP (temporary title)

The BPS Board of Directors completed the critical pharmacy petition review during their Spring board meeting on April 12, 2013 and have voted to recognize criticalcare pharmacy as the seventh BPS specialty. The petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association, and American Society of Health-System Pharmacists.

The petitioning organizations have defined Critical Care Pharmacy practice as follows:

Critical care pharmacy practice specializes in the delivery of patient care services by pharmacists, asintegral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients. The practice requires informed, rapid assessment of clinical data for patients whose pharmacokinetic and pharmacodynamic parameters differ substantially from the non-critically ill patient. Pharmacists in this practice are required to review, analyze, and frequently reassess multifaceted clinical and technological information to make reasoned decisions for highly dynamic patients with life-threatening conditions and complex medication regimens.

The next steps in the specialty certification process are outlined below:

  • BPS will issue a call, on May 3, 2013, for nominations to serve on the Critical Care Pharmacy Specialty Council. The closing date for nominations will be August 2, 2013.
  • BPS will appoint the nine-member, Critical Care Pharmacy Specialty Council by September 15, 2013.
  • The Critical Care Pharmacy Specialty Council will convene, on dates to be determined, in the Fall of 2013.
  • Critical Care Pharmacy Item Writing will begin between the fourth quarter of 2013 and the first quarter of 2014.
  • It is anticipated that the initial certification examination will be administered in 2015.

Nuclear Pharmacy

Board Certified Nuclear Pharmacist — BCNP

Nuclear Pharmacy seeks to improve and promote the public health through the safe and effective use of radioactive drugs for diagnosis and therapy. A nuclear pharmacist, as a member of the nuclear medicine team, specializes in the procurement, compounding, quality control testing, dispensing, distribution, and monitoring of radiopharmaceuticals. In addition, the nuclear pharmacist provides consultation regarding health and safety issues, as well as the use of non-radioactive drugs and patient care. Those who are granted certification in this specialty may use the designation Board Certified Nuclear Pharmacist and the initials BCNP, as long as certification is valid.

Eligibility Requirements

The minimum requirements for certification in nuclear pharmacy are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or program outside the U.S. that qualifies the individual to practice in the jurisdiction. Foreign trained pharmacists must pass the Foreign Pharmacy Graduate Examination Committee (FPGEC) examination.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction
  • 4,000 hours of training/experience in nuclear pharmacy practice
  • Achieving a passing score on the Nuclear Pharmacy Specialty Certification Examination

The required 4,000 hours of experience may be earned in a variety of settings.

Academic-up to 2,000 hours:

  • Undergraduate courses in nuclear pharmacy: up to 100 hours experience for every quarter credit hour or 150 hours experience for every semester credit hour, to a maximum of 1,500 hours
  • Postgraduate courses in nuclear pharmacy: up to 100 hours experience for every quarter credit hour or 150 hours experience for every semester credit hour, to a maximum of 1,500 hours
  • MS or PhD degree in nuclear pharmacy: 2,000 hours
  • Successful completion of the Nuclear Pharmacy Certificate Program offered by Purdue University (217 hours) or The Ohio State University (214 hours), or the Nuclear Education Online (NEO) Program offered by the Universities of New Mexico and Arkansas (250 hours). Credit for other courses will be assessed on a case-by-case basis.

Training/Practice-up to 4,000 hours:

  • Residency in nuclear pharmacy: hour-for-hour credit to a maximum of 2,000 hours
  • Internship to satisfy requirements of state boards of pharmacy: hour-for-hour credit in a licensed nuclear pharmacy or facility authorized to handle radioactive materials, to a maximum of 2,000 hours
  • Nuclear pharmacy practice: hour-for-hour credit in a licensed nuclear pharmacy or health care facility approved by state or federal agencies to handle radioactive materials, to a maximum of 4,000 hours.

Examination Content

(Refer to the Nuclear Pharmacy Content Outline for details.)

  • Domain 1: Drug Order Provision (66% of the examination)
    • Subdomain A: Procurement (8% of the examination)
    • Subdomain B: Compounding (26% of the examination)
    • Subdomain C: Quality Assurance (9% of the examination)
    • Subdomain D: Dispensing (23% of the examination)
  • Domain 2: Health and Safety (24% of the examination)
  • Domain 3: Drug Information Provision (10% of the examination)

Recertification

Recertification for Board Certified Nuclear Pharmacists (BCNP) is a three-step process:

  • Self-evaluation: Review of the nuclear pharmacy practice activities/functions that have changed since initial certification or last recertification
  • Peer review: Documentation of nuclear pharmacy practice activities over the seven year certification period, which are then reviewed by the Specialty Council on Nuclear Pharmacy
  • Formal Assessment:This assessment of a practitioner’s knowledge and skills will be accomplished through one of two methods:

A BCNP recertifying is required to earn 70 hours over the seven year certification period. At least 30 of these hours MUST be earned within the last three years of the certification period.There are no other restrictions as to which lessons in which years may be used to obtain the required number of hours, other than the lesson must have been issued in 1996 or thereafter (Volume V or later Volumes).

A current, active license to practice pharmacy is required for recertification.

As part of the recertification process, every BCNP is asked to complete an annual practice report form provided by BPS. The information is compiled by BPS at the beginning of the recertification process and sent to the BCNP for verification and updating. At the time of recertification, the BCNP is also required to certify that (s) he is not currently under suspension by either the U.S. Nuclear Regulatory Commission or a state Radiation Control Organization.

Nutrition Support Pharmacy

Board Certified Nutrition Support Pharmacist — BCNSP

Nutrition support pharmacy addresses the care of patients who receive specialized nutrition support, including parenteral and enteral nutrition. The nutrition support pharmacist has responsibility for promoting maintenance and/or restoration of optimal nutritional status, designing and modifying treatment according to the needs of the patient. The nutrition support pharmacist has responsibility for direct patient care and often functions as a member of a multidisciplinary nutrition support team. Those who are granted certification in this specialty may use the designation Board Certified Nutrition Support Pharmacist and the initials BCNSP, as long as certification is valid.

Elibigility Requirements

The minimum requirements for this specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction.
  • Completion of three (3) years practice experience with at least 50% of time spent in nutrition support pharmacy activities (as defined by the BPS Nutrition Support Content Outline)
    OR
    Completion of a (PGY2) residency* in nutrition support pharmacy.
    *Effective January 1, 2013, only residencies accredited by the American Health-System Pharmacists are creditable for this purpose.
  • Achieving a passing score on the Nutrition Support Pharmacy Specialty Certification Examination.

Examination Content

(refer to the Nutrition Support Pharmacy Content Outlinefor details)

  • Domain 1: Clinical Practice/Provision of Individualized Nutrition Support to Patients (68% of the examination)
    • Subdomain A: Assessment (21% of the examination)
    • Subdomain B: Develop and Implement a Therapeutic Plan of Care (21% of the examination)
    • Subdomain C: Monitoring and Clinical Management (26% of the examination)
  • Domain 2: Management of Nutrition Support Operations (20% of the examination)
    • Subdomain A: Patient Care Management (12% of the examination)
    • Subdomain B: Compounding Operations (8% of the examination)
  • Domain 3: Advancement of Nutrition Support Practice (12% of the examination)

Recertification

Recertification for Board Certified Nutrition Support Pharmacists (BCNSP) is based on the following activities:

  • Earning a minimum of 30 hours of continuing education in nutrition support with no less than 10 hours earned every two years. These hours must be from providers approved by the Accreditation Council for Pharmacy Education (ACPE).
  • Achieving a passing score on the 100-item, multiple-choice recertification examination, which is based on the content outline of the certification examination

A current, active license to practice pharmacy is required for recertification.

Oncology Pharmacy

Board Certified Oncology Pharmacist — BCOP

Oncology pharmacy specialists recommend, design, implement, monitor and modify pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. Those who are granted certification in this specialty may use the designation Board Certified Oncology Pharmacist and the initials BCOP, as long as certification is valid.

Eligibility Requirements

The minimum requirements for this specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction.
  • Completion of four (4) years of practice experience with at least 50% of time spent in oncology pharmacy activities (as defined by the BPS oncology pharmacy content outline)
    OR
    Completion of a specialty (PGY2) residency* in oncology pharmacy plus one (1) additional year of practice with at least 50% of time spent in oncology pharmacy activities (as defined by the BPS oncology pharmacy content outline)
    * Effective January 1, 2013, only residencies accredited by the American Society of Health-System Pharmacists are creditable for this purpose.
  • Achieving a passing score on the Oncology Pharmacy Specialty Certification Examination

Examination Content

(Refer to the Oncology Pharmacy Content Outline for details)

  • Domain 1: Clinical Skills and Therapeutic Management. (60% of the examination)
  • Domain 2: Generation, Interpretation, and Dissemination of Information. (20% of the examination)
  • Domain 3: Guidelines, Policies, and Standards. (15% of the examination)
  • Domain 4: Public Health and Advocacy. (5% of the examination)

Recertification

Recertification for Board Certified Oncology Pharmacists (BCOP) requires assessment of a practitioner’s knowledge and skills through one of two methods:

A current, active license to practice pharmacy is required for recertification.

Pharmacotherapy

Board Certified Pharmacotherapy Specialist — BCPS

Pharmacotherapy is that area of pharmacy practice that is responsible for ensuring the safe, appropriate, and economical use of drugs in patient care. The pharmacotherapy specialist has responsibility for direct patient care, often functions as a member of a multidisciplinary team and is frequently the primary source of drug information for other healthcare professionals. Those who are granted certification in this specialty may use the designation Board Certified Pharmacotherapy Specialist and the initials BCPS, as long as certification is valid.

Eligibility Requirements

The minimum requirements for this specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction.
  • Completion of three (3) years of practice experience with at least 50% of time spent in pharmacotherapy activities (as defined by the BPS Pharmacotherapy Content Outline)
    OR
    Completion of a PGY1 residency *. *Effective January 1, 2013, only residencies accredited by the American Society of Health-System Pharmacists are creditable for this purpose.
  • Achieving a passing score on the Pharmacotherapy Specialty Certification Examination

Examination Content

(Refer to the Pharmacotherapy Content Outlinefor details.)

  • Domain 1: Patient-specific Pharmacotherapy (60% of the examination)
  • Domain 2: Retrieval, generation, interpretation and dissemination of knowledge in pharmacotherapy (25% of the examination)
  • Domain 3: Systems and Population-based Pharmacotherapy (15% of the examination)

Recertification

Recertification for Board Certified Pharmacotherapy Specialists (BCPS) is an assessment of a practitioner’s knowledge and skills through one of two methods:

  • Achieving a passing score on the 100-item, multiple-choice objective recertification examination, based on the content outline of the certification examination; OR
  • Earning 120 hours of continuing education credit provided by a professional development program approved by BPS.

The continuing education option for recertification was implemented in 1994 with BPS’ designation of the American College of Clinical Pharmacy’s Pharmacotherapy Self – Assessment Program (PSAP) as an acceptable professional development program for recertification. In 2011, BPS approved two more options for recertification through ACCP, the Pharmacotherapy Preparatory Review and Recertification Course as well as the Clinical Reasoning Series. More information on these programs can be found on ACCP’s website at www.accp.com/careers/boardbcps.aspx.

BCPS recertifying are required to earn 120 hours of credit from approved programs. No more than 60 hours may be earned prior to the end of the fourth year of certification. However, all 120 hours may be earned during the last three years of certification. Those using PSAP for recertification should note that there is a postmark deadline for submission of the tests for recertification credit. The BCPS Expiration Date of a PSAP module determines the year the program is creditable, regardless of when it is completed and submitted by the certificant. For example, a module due on January 20 of a particular year will only be credited for that year, even if it was submitted in December of the previous year. You can download a PSAP completion chart by clicking here.

Please note the following regarding the additional continuing education offerings for recertification:

  • The “Pharmacotherapy Preparatory Review and Recertification Course” may be completed for recertification credit, either in live or home study format, up to two times, in nonconsecutive years during the 7-year recertification cycle.
  • Board Certified Pharmacotherapy Specialists may participate in the “Clinical Reasoning Series” every year throughout their 7-year recertification cycle to earn recertification credit.

A current, active license to practice pharmacy is required for recertification.

Pediatric Pharmacy

Board Certified Pediatric Pharmacist BCPP (Pediatric, temporary title)

The BPS Board of Directors completed the pediatric pharmacy petition review during theirSpring board meeting on April 12, 2013 and have voted to recognize pediatric pharmacy as the eighth BPS specialty. The petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association, American Society of Health-System Pharmacists and the Pediatric Pharmacy Advocacy Group.

The petitioning organizations have defined Pediatric Pharmacy practice as follows:

Pediatric pharmacy practice specializes in the delivery of patient care services by pharmacists that ensures the safe and effective use of medications for all children from neonates through adolescents. The practice includes direct patient care for children, often provided through interprofessional healthcare teams, as well as advocacy and education for children and their families, wellness and health promotion, and activities that advance knowledge and skills in pediatric pharmacy.

The next steps in the specialty certification process are outlined below:

  • BPS will issue a call, on May 3, 2013, for nominations to serve on the Pediatric Pharmacy Specialty Council. The closing date for nominations will be August 2, 2013.
  • BPS will appoint the nine-member, Pediatric Pharmacy Specialty Council by September 15, 2013.
  • The Pediatric Pharmacy Specialty Council will convene, on dates to be determined, in the Fall of 2013.
  • Pediatric Pharmacy Item Writing will begin between the fourth quarter of 2013 and the first quarter of 2014.
  • It is anticipated that the initial certification examination will be administered in 2015.

Psychiatric Pharmacy

Board Certified Psychiatric Pharmacist — BCPP

Psychiatric pharmacy addresses the pharmaceutical care of patients with psychiatric-related illnesses. As a member of a multidisciplinary treatment team, the psychiatric pharmacy specialist is often responsible for optimizing drug treatment and patient care by conducting such activities as monitoring patient response, patient assessment, recognizing drug-induced problems, and recommending appropriate treatment plans. Those who are granted certification in this specialty may use the designation Board Certified Psychiatric Pharmacist and the initials BCPP, as long as certification is valid.

Eligibility Requirements

The minimum requirements for this specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction.
  • Completion of four (4) years of practice with at least 50% of time spent in psychiatric pharmacy activities (as defined by the BPS Psychiatric Pharmacy Content Outline)
    OR
    Completion of a specialty (PGY2) residency* in psychiatric pharmacy plus one (1) additional year of practice with at least 50% of time spent in psychiatric pharmacy activities (as defined by the BPS Psychiatric Pharmacy Content Outline)
    *Effective January 1, 2013, only residencies accredited by the American Society of Health-System Pharmacists are creditable for this purpose.
  • Achieving a passing score on the Psychiatric Pharmacy Specialty Certification Examination

Examination Content

(Refer to the Psychiatric Pharmacy Content Outlinefor details.)

  • Domain 1: Clinical Skills and Therapeutic Management (65% of the examination)
  • Domain 2: Education and Dissemination of Information (25% of the examination)
  • Domain 3: Clinical Administration (10% of the examination)

Recertification

Recertification of Board Certified Psychiatric Pharmacists (BCPP) requires an assessment of a practitioner’s knowledge and skills through one of two methods:

  • Achieving a passing score on the 100-item multiple choice recertification examination, based on the content outline of the certification examination;
    OR
  • Earning 100 hours of continuing education credit** provided by a professional development program approved by BPS. The BPS-approved professional development program for Psychiatric Pharmacy is currently offered by the College of Psychiatric and Neurologic Pharmacists (CPNP). Please review the special note below. Contact CPNP for specific information about their program offerings that will qualify for BCPP recertification credit.

A current, active license to practice pharmacy is required for recertification.

** Special Notes:

  • BCPPs recertifying via continuing education are required to complete the Review Course a minimum of once during their 7-year recertification cycle.
  • BCPPs recertifying via continuing education can use the Review Course a maximum of twice for recertification credit during their 7-year recertification cycle.
  • The Review Course is revised and released every other year on the event year (2012, 2014…). Given this revision cycle, individuals cannot repeat the current edition of the Review Course for BCPP Recertification or ACPE credit.